EP 1098893 A1 20010516 - CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS
Title (en)
CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS
Title (de)
ZYKLISCHE VERBINDUNGEN DIE ANWENDUNG FINDEN BEI DER BEHANDLUNG VON DYSLIPIDÄMIEN, ATHEROSKLEROSE UND DIABETIS, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DIE DIESE ENTHALTEN UND VERFAHREN ZU IHRER HERSTELLUNG
Title (fr)
COMPOSES CYCLIQUES UTILES DANS LE TRAITEMENT DE DYSLIPIDEMIE, D'ATHEROSCLEROSE ET DE DIABETES, COMPOSITIONS PAHARMACEUTIQUES ET PROCEDES DE PREPARATION ASSOCIES
Publication
Application
Priority
- EP 9904831 W 19990709
- FR 9809164 A 19980717
Abstract (en)
[origin: US6528538B1] The present invention relates to cyclic compounds which are of the class of compounds of formula I wherein X and Y represent an oxygen atom and to processes for preparing such compounds. The compounds are useful in the treatment of dyslipidemia, atherosclerosis, and diabetes.
IPC 1-7
IPC 8 full level
A61K 31/357 (2006.01); A61K 31/381 (2006.01); A61K 31/4035 (2006.01); A61K 31/443 (2006.01); A61K 31/4433 (2006.01); A61K 31/453 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); C07C 33/36 (2006.01); C07C 33/46 (2006.01); C07D 311/82 (2006.01); C07D 319/06 (2006.01); C07D 319/08 (2006.01); C07D 405/06 (2006.01); C07D 407/04 (2006.01); C07D 409/04 (2006.01); C07D 493/10 (2006.01)
CPC (source: EP US)
A61P 3/00 (2018.01 - EP); A61P 3/06 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 9/10 (2018.01 - EP); C07D 319/06 (2013.01 - EP US); C07D 319/08 (2013.01 - EP US); C07D 405/06 (2013.01 - EP US); C07D 407/04 (2013.01 - EP US); C07D 409/04 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
US 6528538 B1 20030304; AT E235485 T1 20030415; AU 5034799 A 20000207; AU 753287 B2 20021017; BR 9912138 A 20010410; CA 2337481 A1 20000127; CN 1309655 A 20010822; DE 69906303 D1 20030430; DE 69906303 T2 20031211; DK 1098893 T3 20030707; EP 1098893 A1 20010516; EP 1098893 B1 20030326; ES 2192853 T3 20031016; FR 2781222 A1 20000121; HK 1039615 A1 20020503; HU P0103411 A2 20020429; HU P0103411 A3 20020828; ID 27854 A 20010426; JP 2002520407 A 20020709; KR 20010070966 A 20010728; NO 20010266 D0 20010116; NO 20010266 L 20010116; PL 345397 A1 20011217; PT 1098893 E 20030829; SK 482001 A3 20010911; WO 0004011 A1 20000127; ZA 200101303 B 20020515
DOCDB simple family (application)
US 74375901 A 20010116; AT 99934643 T 19990709; AU 5034799 A 19990709; BR 9912138 A 19990709; CA 2337481 A 19990709; CN 99808783 A 19990709; DE 69906303 T 19990709; DK 99934643 T 19990709; EP 9904831 W 19990709; EP 99934643 A 19990709; ES 99934643 T 19990709; FR 9809164 A 19980717; HK 02100966 A 20020207; HU P0103411 A 19990709; ID 20010261 A 19990709; JP 2000560117 A 19990709; KR 20017000647 A 20010116; NO 20010266 A 20010116; PL 34539799 A 19990709; PT 99934643 T 19990709; SK 482001 A 19990709; ZA 200101303 A 20010215